BAP1 and hepatocellular carcinoma: Twenty-two (45.83%) of the 48 cases showed a higher expression in the HCC tumors than their corresponding non-tumorous liver tissues (Fig. 2A); 17 (35.43%) cases had comparable expression of BAP1 between the two; and 9 (18.75%) cases had lower BAP1 expression in HCCs than the corresponding non-tumorous livers.